AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson's Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases

AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases

Related Keywords

Sweden ,Gothenburg ,Vastra Gotalands Lan , ,Bayer Ag ,Drug Development ,Research Triangle Park ,Asklepios Biopharmaceutical Inc ,Triangle Park ,Asklepios Biopharmaceutical ,Therapy Conference ,European Time ,